Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6255Fax+1 614-293-8518
Summary
- Dr. Na Li is a general gastroenterologist and hepatologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and The OSUCCC - James. She received her medical degree from Xi'an Jiaotong Medical University in China and has been in practice at OSU for 12 years. She also speaks Chinese (Mandarin). She specializes in general hepatology especially fatty liver, and is experienced in general gastroenterology, inflammatory bowel disease. She is the principal investigator for multiple clinical trials on fatty liver and has multiple publications.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Gastroenterology, 2013- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2010
Xi'an Jiaotong Medical UniversityClass of 1998
Certifications & Licensure
OH State Medical License 2013 - 2026
NY State Medical License 2010 - 2014- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 7 citationsImpacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease ci...Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett
Alimentary Pharmacology & Therapeutics. 2024-05-01 - 1 citationsThe impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.Mohamed I Elsaid, John F P Bridges, Khalid Mumtaz, Na Li, Lindsay Sobotka
Plos One. 2024-01-01 - 7 citationsMetabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease.Mohamed I Elsaid, John F P Bridges, Na Li, Vinod K Rustgi
Gastro Hep Advances. 2022-01-01
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
